Screening for Viral Hepatitis and Hepatocellular Cancer.
about
2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44.Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity.Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells
P2860
Screening for Viral Hepatitis and Hepatocellular Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Screening for Viral Hepatitis and Hepatocellular Cancer.
@en
type
label
Screening for Viral Hepatitis and Hepatocellular Cancer.
@en
prefLabel
Screening for Viral Hepatitis and Hepatocellular Cancer.
@en
P1476
Screening for Viral Hepatitis and Hepatocellular Cancer.
@en
P2093
Andrew M Cameron
P304
P356
10.1016/J.SUC.2015.05.005
P577
2015-06-16T00:00:00Z